Obesity Trials in Amsterdam, Netherlands
Conditions / Obesity / Amsterdam, Netherlands
Obesity is a medical condition with active clinical research programs worldwide.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05536804 | A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02628301 | Microvascular Dysfunction and the Development of Whole-body Insulin Resistance | COMPLETED | NA |
| NCT05651724 | Global Research Initiative for Patients Screening on MASH | RECRUITING | — |
| NCT05567796 | A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01272219 | Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes | COMPLETED | PHASE3 |
| NCT04442334 | The European NAFLD Registry | RECRUITING | — |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | RECRUITING | — |
| NCT01545492 | Testing the Developmental Origins Hypothesis | UNKNOWN | — |
| NCT01281228 | The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes | COMPLETED | NA |
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | RECRUITING | PHASE3 |